|
DHFR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.14120000000739E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.7875000000025E-05 |
| Normal-vs-Stage2 |
4.776300E-03 |
| Normal-vs-Stage3 |
1.083000E-03 |
| Normal-vs-Stage4 |
3.736100E-02 |
| Stage1-vs-Stage2 |
7.032200E-01 |
| Stage1-vs-Stage3 |
9.357000E-01 |
| Stage1-vs-Stage4 |
5.524600E-01 |
| Stage2-vs-Stage3 |
6.955400E-01 |
| Stage2-vs-Stage4 |
4.766400E-01 |
| Stage3-vs-Stage4 |
6.258000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.420000E-04 |
| Normal-vs-AfricanAmerican |
2.31100000247508E-08 |
| Normal-vs-Asian |
1.069520E-02 |
| Caucasian-vs-AfricanAmerican |
8.615500E-04 |
| Caucasian-vs-Asian |
3.644400E-01 |
| AfricanAmerican-vs-Asian |
6.511200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.34330000001182E-06 |
| Normal-vs-Female |
2.688100E-02 |
| Male-vs-Female |
2.055900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.809500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.363000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.036200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.221810E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.469400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.942400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.620000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.760600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.913600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.503800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.843300E-03 |
| Normal-vs-Grade 2 |
3.016000E-03 |
| Normal-vs-Grade 3 |
1.352860E-04 |
| Normal-vs-Grade 4 |
2.339100E-03 |
| Grade 1-vs-Grade 2 |
9.869700E-02 |
| Grade 1-vs-Grade 3 |
3.158600E-01 |
| Grade 1-vs-Grade 4 |
4.909200E-01 |
| Grade 2-vs-Grade 3 |
2.507600E-01 |
| Grade 2-vs-Grade 4 |
2.811200E-01 |
| Grade 3-vs-Grade 4 |
8.088200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.820000E-02 |
| Normal-vs-ccB subtype |
5.90700000024924E-07 |
| ccA subtype-vs-ccB subtype |
2.779900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.361100E-04 |
| Normal-vs-N1 |
8.294800E-01 |
| N0-vs-N1 |
2.479600E-01 |
|
|
